p53 Testing for Li‐Fraumeni and Li‐Fraumeni‐Like Syndromes
Authors:
Open Access
- 1 March 2008
- journal article
- unit
- Published by Wiley in Current Protocols in Human Genetics
- Vol. 57 (1) , 10.10.1-10.10.11
Abstract
Li‐Fraumeni Syndrome (LFS; OMIM #151623) is an autosomal dominant cancer predisposition syndrome characterized by early onset tumors including sarcomas, breast cancer, leukemia, brain tumors, and adrenocortical carcinoma. Li‐Fraumeni syndrome is primarily attributed to germline mutations in the p53 tumor suppressor gene, which encodes tumor protein 53. In addition to germline p53 mutations, the p53 gene is the most commonly mutated gene in human cancers, with as much as 50% of tumors containing somatic p53 mutations. This unit provides a protocol to perform germline mutation analysis of the p53 gene. The protocol includes steps for amplification and sequencing of the entire coding region of the p53 gene (exons 2 to 11). The protocol was designed for detecting germline alterations from DNA extracted from blood; however, with some additional optimization, it could also be used to detect somatic mutations in DNA extracted from tumors. Curr. Protoc. Hum. Genet. 57:10.10.1‐10.10.11. © 2008 by John Wiley & Sons, Inc.Keywords
This publication has 38 references indexed in Scilit:
- Inherited cancer susceptibility syndromes in paediatric practiceJournal of Paediatrics and Child Health, 2007
- Most spontaneous tumors in a mouse model of Li-Fraumeni syndrome do not have a mutator phenotypeCarcinogenesis, 2006
- Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with CamptothecinJournal of Biological Chemistry, 2002
- Chk2 kinase — a busy messengerNature Reviews Molecular Cell Biology, 2001
- Relative frequency and morphology of cancers in carriers of germline TP53 mutationsOncogene, 2001
- Genetic Testing for Cancer PredispositionAnnual Review of Medicine, 2001
- Sensitivity and predictive value of criteria for p53germline mutation screeningJournal of Medical Genetics, 2001
- Mechanisms of Hormonal Carcinogenesis in the p53+/- Hemizygous Knockout Mouse: Studies With DiethylstilbestrolToxicologic Pathology, 2001
- Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.Proceedings of the National Academy of Sciences, 1995
- Choroid plexus tumors in the breast cancer–sarcoma syndromeCancer, 1990